DGAP-News: Prospectus
(firmenpresse) - Veloxis Pharmaceuticals A/S
15.10.2012 09:44
---------------------------------------------------------------------------
Not for release, publication or distribution in the United States, Canada,
Australia or Japan
This prospectus does not constitute an offer to sell or the solicitation of an
offer to buy the securities of Veloxis Pharmaceuticals A/S (the 'Securities')
in the United States or in any other jurisdiction. The Securities may not be
offered or sold in the United States absent registration or an exemption from
registration under the U.S. Securities Act of 1933, as amended. The issuer of
the Securities has not registered, and does not intend to register, any portion
of the Offering in the United States or in any jurisdiction outside Denmark,
and does not intend to conduct a public offering of the Securities in the
United States or in any other jurisdiction outside Denmark. Copies of this
prospectus are not being made and may not be distributed or sent into the
United States, Canada, Australia or Japan or any other jurisdiction where such
distribution is not permitted under the applicable laws of such jurisdiction.
The prospectus is attached.
Click on, or paste the following link into your web browser, to view the associated documents
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=406245
News Source: NASDAQ OMX
15.10.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Veloxis Pharmaceuticals A/S
Dänemark
Phone:
Fax:
E-mail:
Internet:
ISIN: DK0060048148
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.10.2012 - 09:44 Uhr
Sprache: Deutsch
News-ID 192143
Anzahl Zeichen: 14844
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 136 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Prospectus"
steht unter der journalistisch-redaktionellen Verantwortung von
Veloxis Pharmaceuticals A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
